Saturday 17 October 2026 Export SUPN’s income statement to Excel — free account

Supernus Pharmaceuticals, Inc.

SUPN Healthcare Drug Manufacturers Specialty & Generic

Supernus Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $719.0 million, up 8.63% from fiscal 2024. In the quarter to June 2026, revenue grew 32.4%, EPS fell 352.5% and free cash flow fell 109.3%, each against the same quarter a year earlier.

37.88 1.69 −4.27%

Follow SUPN

Alert me

Market cap: $2.3B
P/E: 0.0×
Fwd P/E: 103×
Dividend yield: —
F-score: 5/9
Altman Z: 5.41
Beneish M: −2.54
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	5	5	3	+8 more TTM periods Free account
ROE Full definition →	(10.49%)	(2.75%)	(3.68%)	(1.86%)
ROA Full definition →	(7.82%)	(2.04%)	(2.73%)	(1.38%)
ROIC Full definition →	(12.37%)	(5.45%)	(5.17%)	(3.00%)
Return on Tangible Assets Full definition →	(28.44%)	(7.89%)	(12.18%)	(6.98%)
Average Days of Receivables Full definition →	93.03	85.60	95.34	91.72
Free Cash Flow per Share Full definition →	0.32	1.44	0.81	1.25
Free Cash Flow Full definition →	18.33	83.26	45.99	70.75
Capital Expenditures Full definition →	(1.58)	—	(1.34)	(1.12)
Other line items
Cash ROIC Full definition →	1.31%	5.70%	3.36%	5.32%
Accounts Receivable Turnover Full definition →	4.71	4.74	4.36	4.30
Accounts Payable Turnover Full definition →	1.06	0.92	0.81	0.84
Inventory Turnover Full definition →	1.55	1.20	1.09	1.08
Average Days of Payables Full definition →	399.74	449.62	527.71	510.52
Days of Inventory on Hand Full definition →	309.32	386.64	403.30	373.21
Tax Rate Full definition →	(0.11)	(0.41)	(0.21)	(0.08)
Research and Development Expense of Revenue Full definition →	15.18%	15.29%	14.78%	15.71%
Selling, General and Administrative Expense of Revenue Full definition →	67.54%	67.04%	67.54%	64.94%
Share Based Compensation of Revenue Full definition →	4.17%	4.31%	4.60%	4.55%
Interest Coverage Full definition →	(56.36)	—	—	—
Operating CF/Net income Full definition →	(0.18)	(2.87)	(1.23)	(3.76)
Depreciation/Fixed assets Full definition →	9.88	9.63	8.55	7.78
Capex/Depreciation Full definition →	(0.02)	0.00	(0.01)	(0.01)
Revenue per Share Full definition →	14.30	13.48	12.74	12.05
Operating CF per Share Full definition →	0.34	1.44	0.84	1.27
Capex per Share Full definition →	(0.03)	0.00	(0.02)	(0.02)
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly